/
ABT
$105.00-$2.39 (-2.21%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$182.7B
1,730M shares
52-week range
$81.97 – $137.49
41% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
CS
Change$-15.31
Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
www.abbott.com- Employees
- 115,000
- IPO / List date
- Apr 19, 1949
- HQ
- ABBOTT PARK, IL
Held by traders on TradeandTell
No one on the platform currently holds ABT.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,238,666 | $127.2M |
| Bridgewater Associatesas of 2026-03-31 | 117,051 | $12.0M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 2.36% ($2.48/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-15 | $0.6300 | 2026-08-17 |
| 2026-04-15 | $0.6300 | 2026-05-15 |
| 2026-01-15 | $0.6300 | 2026-02-13 |
| 2025-10-15 | $0.5900 | 2025-11-17 |
| 2025-07-15 | $0.5900 | 2025-08-15 |
| 2025-04-15 | $0.5900 | 2025-05-15 |
| 2025-01-15 | $0.5900 | 2025-02-14 |
| 2024-10-15 | $0.5500 | 2024-11-15 |
| 2024-07-15 | $0.5500 | 2024-08-15 |
| 2024-04-12 | $0.5500 | 2024-05-15 |
Recent trades on TradeandTell
No one on the platform has traded ABT yet.
